HHS Is Thinking Big about smallpox.(LETTERS)

The Washington Times (Washington, DC), June 28, 2002 | Go to article overview
Save to active project

HHS Is Thinking Big about smallpox.(LETTERS)


On June 20, the Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention delivered recommendations to the Department of Health and Human Services (HHS) that expand the current smallpox vaccination policy. In addition to laboratory personnel working with smallpox, these recommendations broaden the existing smallpox vaccination policy to include those individuals who would be most likely to come in contact with smallpox victims in the event of a biological attack.

Charles V. Pena's "Small thinking on smallpox" (Commentary, June 20) criticizes the revised ACIP smallpox vaccination recommendations as misguided and manifesting a lack of knowledge about the complexity of the issues that demand address. Specific criticisms of direct quotes taken from Mr. Pena's article include:

Error No. 1: "The Centers for Disease Control and Prevention (CDC) are meeting behind closed doors." Not true. During the past month, public forums were held in New York City, San Francisco, San Antonio, St. Louis and Washington. Furthermore, the ACIP meeting held in Atlanta on June 19 and 20 welcomed and received public comment.

Error No. 2: "The bottom line is that an unvaccinated population is completely vulnerable and an attractive target. A better approach than leaving the population exposed would be to take preventative measures." This is untrue and dangerously misleading.

The smallpox vaccine, vaccinia, is a live virus that is closely related to smallpox. Vaccines are infectious and may unintentionally transmit the virus to individuals who may develop life-threatening complications. Because there is a risk of endangering others, this is not simply an issue of an individual's right to choose. The health of the American public must be our primary concern.

The smallpox vaccine is the least safe vaccine ever used in the United States, with 2 to 4 deaths per million vaccines and another 3,000 severe and potentially disabling complications expected. The vaccines available are currently labeled as "Investigational New Drugs" that require the approval of an Institutional Review Board (IRB) for participation in clinical trials. Appropriate informed consent, screening, patient follow-up and administrative oversight by federal, state and local public health officials would be required, as well as policy decisions regarding a host of legal and procedural issues, including responsibility for liability and costs incurred.

The rest of this article is only available to active members of Questia

Sign up now for a free, 1-day trial and receive full access to:

  • Questia's entire collection
  • Automatic bibliography creation
  • More helpful research tools like notes, citations, and highlights
  • Ad-free environment

Already a member? Log in now.

Notes for this article

Add a new note
If you are trying to select text to create highlights or citations, remember that you must now click or tap on the first word, and then click or tap on the last word.
Loading One moment ...
Project items
Cite this article

Cited article

Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

Cited article

HHS Is Thinking Big about smallpox.(LETTERS)


Text size Smaller Larger
Search within

Search within this article

Look up

Look up a word

  • Dictionary
  • Thesaurus
Please submit a word or phrase above.
Print this page

Print this page

Why can't I print more than one page at a time?

While we understand printed pages are helpful to our users, this limitation is necessary to help protect our publishers' copyrighted material and prevent its unlawful distribution. We are sorry for any inconvenience.
Full screen

matching results for page

Cited passage

Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

Cited passage

Welcome to the new Questia Reader

The Questia Reader has been updated to provide you with an even better online reading experience.  It is now 100% Responsive, which means you can read our books and articles on any sized device you wish.  All of your favorite tools like notes, highlights, and citations are still here, but the way you select text has been updated to be easier to use, especially on touchscreen devices.  Here's how:

1. Click or tap the first word you want to select.
2. Click or tap the last word you want to select.

OK, got it!

Thanks for trying Questia!

Please continue trying out our research tools, but please note, full functionality is available only to our active members.

Your work will be lost once you leave this Web page.

For full access in an ad-free environment, sign up now for a FREE, 1-day trial.

Already a member? Log in now.

Are you sure you want to delete this highlight?